Dr. Rhoda Au, Professor of Anatomy & Neurobiology, Neurology, Medicine and Epidemiology at Boston University Chobanian & Avedisian School of Medicine and School of Public Health, will discuss her pioneering work aimed at developing digital biomarkers. Dr. Au is studying whether data on Alzheimer’s-related characteristics collected through smartphones and tablets can help us detect Alzheimer’s years before symptoms present. Her research, which is funded through the ADDF’s Diagnostics Accelerator, will pave the way for early diagnosis and intervention.
“Tomorrow’s Breakthroughs Today” features world-class scientists discussing the path toward new, cutting-edge treatments for Alzheimer’s disease. Now in its fourth season and second at The Four Arts, this lecture series, founded in partnership with Heidi and Tom McWilliams, invites three top investigators to share the latest breaking updates on their research with moderator Dr. Howard Fillit, Co-Founder and Chief Science Officer of the Alzheimer’s Drug Discovery Foundation (ADDF). Founded in 1998 by Leonard A. and Ronald S. Lauder, the ADDF is dedicated to rapidly accelerating the development of novel therapeutics and biomarkers to prevent, treat, and cure Alzheimer’s disease and related dementias.
Presented by the Alzheimer’s Drug Discovery Foundation in partnership with Heidi and Tom McWilliams
